Leader Biochemical Group 86--029-68895030 info@leader-biogroup.com
China Northwest Factory Manufacturer n-Docosanol / Behenyl Alcohol / 1-Docosanol CAS 661-19-8 For stock delivery

China Northwest Factory Manufacturer n-Docosanol / Behenyl Alcohol / 1-Docosanol CAS 661-19-8 For stock delivery

  • Purity
    99.9%
  • Use
    Health Care
  • Origin
    China
  • Package
    1KG/Tin 25KG/Drum*Carton
  • Manufacturer
    XI'AN LEADER BIOCHEMICAL ENGINEERING CO.,LTD
  • Place of Origin
    CHINA
  • Brand Name
    Leader
  • Certification
    ISO,GMP,SGS,HALA,KOSER,HACCP
  • Model Number
    LD
  • Minimum Order Quantity
    25KGS
  • Price
    Negotiate Depend on order quantity
  • Packaging Details
    25KG/Drum
  • Delivery Time
    2-3 working days
  • Payment Terms
    Western Union, MoneyGram, T/T, L/C
  • Supply Ability
    10MTS/Month

China Northwest Factory Manufacturer n-Docosanol / Behenyl Alcohol / 1-Docosanol CAS 661-19-8 For stock delivery

n-Docosanol Basic information
Product Name: n-Docosanol
Synonyms: ALCOHOL C22;BEHENYLIC ALCOHOL;Behenic alcohol;behenicalcohol;Cachalot BE-22;Dehydag wax 22 (lanette);Docosan-1-ol;Docosanol-(1)
CAS: 661-19-8
MF: C22H46O
MW: 326.6
EINECS: 211-546-6
Product Categories: ABREVA;Pharmaceutical Raw Materials;Saturated Higher Alcohols;1-Alkanols;Antivirals for Research and Experimental Use;Biochemistry;Higher Fatty Acids & Higher Alcohols;Monofunctional & alpha,omega-Bifunctional Alkanes;Monofunctional Alkanes;Pharma material;fine chemicals;Inhibitors
Mol File: 661-19-8.mol
n-Docosanol Structure
 
n-Docosanol Chemical Properties
Melting point 65-72 °C(lit.)
Boiling point 180 °C0.22 mm Hg(lit.)
density d75 0.8063 g/ml; d85 0.7986 g/ml; d95 0.7911 g/ml
refractive index n75 1.4360
storage temp. 2-8°C
pka 15.20±0.10(Predicted)
form Pellets or Tablets
color White
Water Solubility Insoluble
Merck 13,3433
BRN 1770470
Stability: Stable. Combustible. Incompatible with strong oxidizing agents.
CAS DataBase Reference 661-19-8(CAS DataBase Reference)
NIST Chemistry Reference 1-Docosanol(661-19-8)
EPA Substance Registry System 1-Docosanol (661-19-8)
 
Safety Information
Safety Statements 24/25
WGK Germany -
RTECS JR1315000
TSCA Yes
HS Code 29051900
Hazardous Substances Data 661-19-8(Hazardous Substances Data)
Toxicity LD50 intraperitoneal in mouse: > 800mg/kg
MSDS Information
Provider Language
1-Docosanol English
ACROS English
SigmaAldrich English
ALFA English
 
n-Docosanol Usage And Synthesis
Chemical Properties 1-DOCOSANOL is white powder
Uses antiviral
Uses n-Docosanol is a binder and an emulsion stabilizer. It is also used to increase a formulation’s viscosity. This is a mixture of fatty alcohols. behenyl alcohol may be used for any number of purposes in a cosmetic formulation, including as an emollient, a binder, an emulsion stabilizer, or to increase a product’s viscosity. It may be derived either synthetically or from plants.
Definition 1-DOCOSANOL is a long-chain, saturated fatty alcohol.
Indications Docosanol (Abreva) is a long-chain saturated alcohol that is clinically effective against HSV. It has in vitro activity against many enveloped viruses, including CMV, influenzavirus, and respiratory syncytial virus.
Docosanol is not directly virucidal; instead, it blocks the entry of the virion into the host cell by inhibiting the fusion of the viral envelope with the host plasma membrane. Because it does not affect viral replication or protein production, it may be less susceptible to the development of resistance than other antiviral drugs.
Pharmaceutical Applications 1-DOCOSANOL is a 22-carbon straight chain alcohol licensed for over-thecounter sales for the topical treatment of herpes labialis. It is thought to act by blocking viral fusion with the host cell, although definitive studies are lacking. The clinical relevance of the antiviral activity has been debated and the place of this medication as a treatment of herpes labialis remains to be established.
Clinical Use Docosanol cream is approved for the over-the-counter treatment of herpes labialis. It shortens the duration of symptoms of cold sores and fever blisters but does not provide symptomatic relief.
Side effects Adverse effects of docosanol are minimal. Skin irritation occurs infrequently. Drug interactions are not anticipated.
Purification Methods Crystallise docosanol from r or chloroform/r. [Beilstein 1 IV 1906.]
 
n-Docosanol Preparation Products And Raw materials
Preparation Products N-TETRATETRACONTANE